Inscription Capital’s Columbia Research Enhanced Core ETF RECS Stock Holding History
Bought
Maintained
Sold
Other funds holding RECS
GI
BWL
Inscription Capital's RECS Position: Q1 2026 in Review
Inscription Capital reduced its Columbia Research Enhanced Core ETF (RECS) stake by 7.1% in Q1 2026, selling an estimated $145K and leaving 46,579 shares worth $1.82M. The position accounts for 0.19% of the portfolio, ranked #90.
Inscription Capital first reported a position in RECS in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.05M in Q4 2025. 175 funds tracked by Wall St. Rank hold RECS as of Q1 2026.
- Inscription Capital held 46,579 shares of Columbia Research Enhanced Core ETF worth $1.82M as of Q1 2026.
- Inscription Capital sold 3,568 Columbia Research Enhanced Core ETF shares in Q1 2026, an estimated $145K.
- Columbia Research Enhanced Core ETF made up 0.19% of Inscription Capital's portfolio in Q1 2026, its #90 holding.
- Inscription Capital first reported a position in Columbia Research Enhanced Core ETF in Q2 2025 and has held it in 4 quarters since.
- Inscription Capital's Columbia Research Enhanced Core ETF position peaked at $2.05M in Q4 2025.
- 175 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q1 2026.
Based on Inscription Capital's 13F filing for Q1 2026, filed 20 Apr 2026.